证券记录 · 已归档季度
VRTX
Vertex Pharmaceuticals Incorporated · Healthcare · Biotechnology
19被追踪持有人
—Δ持有人
46.47M持有股份
$21.77B报告持仓市值
+0新建仓位
−0清仓
所有持股数据：仅限已追踪的 13F 管理人，普通股持仓，报告期 Q2 2024
持股变化趋势
| 季度 | 持有人 | Δ | 股份 | 报告持仓市值 | 新增 | 清仓 |
|---|---|---|---|---|---|---|
| Q2 2026 | 175 | -1 | 212.01M | $105.17B | +5 | −5 |
| Q1 2026 | 178 | 0 | 208.95M | $93.29B | +5 | −6 |
| Q4 2025 | 177 | -1 | 219.78M | $99.62B | +2 | −2 |
| Q3 2025 | 26 | +1 | 120.93M | $47.35B | +1 | −1 |
| Q2 2025 | 23 | +1 | 112.15M | $49.92B | +3 | −2 |
| Q1 2025 | 19 | -2 | 60.41M | $29.28B | — | −2 |
| Q4 2024 | 21 | +1 | 60.08M | $24.19B | +1 | — |
| Q3 2024 | 19 | 0 | 46.24M | $21.49B | — | — |
| Q2 2024 | 19 | — | 46.47M | $21.77B | — | — |
持有人 · Q2 2024
| # | 管理人 | 股份 | Δ股份 | 价值 | 其权重 | 持有 | ||
|---|---|---|---|---|---|---|---|---|
| 1 | Capital World Investors ✦ | 26.71M | — | $12.52B | 2.0% | n/c | 1 | SEC ↗ |
| 2 | Geode Capital Management ✦ (被动) | 6.33M | — | $2.96B | 0.3% | n/c | 1 | SEC ↗ ×2 |
| 3 | Wellington Management ✦ | 4.09M | — | $1.92B | 0.3% | n/c | 1 | SEC ↗ ×8 |
| 4 | Norges Bank ✦ (被动) | 3.43M | — | $1.61B | 0.2% | n/c | 1 | SEC ↗ |
| 5 | T. Rowe Price ✦ | 2.21M | — | $1.04B | 0.1% | n/c | 1 | SEC ↗ ×2 |
| 6 | Renaissance Technologies ✦ | 1.57M | — | $734.20M | 1.2% | n/c | 1 | SEC ↗ |
| 7 | AQR Capital Management ✦ | 536.11K | — | $251.29M | 0.4% | n/c | 1 | SEC ↗ ×4 |
| 8 | Adage Capital Partners ✦ | 335.16K | — | $157.10M | 0.3% | n/c | 1 | SEC ↗ |
| 9 | Two Sigma Investments ✦ | 331.99K | — | $155.61M | 0.4% | n/c | 1 | SEC ↗ |
| 10 | D. E. Shaw & Co. ✦ | 170.06K | — | $79.71M | 0.1% | n/c | 1 | SEC ↗ ×2 |
| 11 | Baillie Gifford ✦ | 167.62K | — | $78.56M | 0.1% | n/c | 1 | SEC ↗ ×4 |
| 12 | Millennium Management ✦ | 142.76K | — | $66.91M | 0.1% | n/c | 1 | SEC ↗ |
| 13 | Marshall Wace ✦ | 127.00K | — | $59.53M | 0.1% | n/c | 1 | SEC ↗ |
| 14 | Citadel Advisors ✦ | 104.59K | — | $49.03M | 0.0% | n/c | 1 | SEC ↗ ×2 |
| 15 | ARK Investment Management ✦ | 75.46K | — | $35.37M | 0.3% | n/c | 1 | SEC ↗ |
| 16 | Tweedy, Browne ✦ | 54.35K | — | $25.47M | 1.2% | n/c | 1 | SEC ↗ |
| 17 | Bridgewater Associates ✦ | 33.23K | — | $15.58M | 0.1% | n/c | 1 | SEC ↗ |
| 18 | Fisher Asset Management ✦ | 28.11K | — | $13.17M | 0.0% | n/c | 1 | SEC ↗ |
| 19 | Gotham Asset Management ✦ | 24.71K | — | $11.58M | 0.1% | n/c | 1 | SEC ↗ |
"持仓权重"= 该持仓占该管理人已申报13F股权价值的比例——即信念度衡量指标。✦ = 精选管理人。
新增买入方
| 本季度无新增被追踪买入方。 |
已清仓
| 本季度无被追踪的退出仓位。 |
全市场背景: 涵盖所有13F申报机构（SEC结构化数据， Q1 2026): 1,678 持有人, 225.07M 股份, $98.10B 已申报. 这是与上方被追踪全域数据不同的较早期间，两者从不混用。
常见共同持仓
该证券的被追踪持有人最常同时持有的其他证券——基于共同持有计数，而非基本面关联。
数据来源: 持股数据来源于已解析的13F普通股持仓（被追踪范围，变动对比集）；内部人行为来自Form 3/4/5；重大持股来自Schedule 13D/13G；所有文件均链接至SEC EDGAR原始申报。
报告期: Q2 2024 ·
方法论 ·
通过API获取此数据